Ausdal Financial Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$768K Buy
9,817
+510
+5% +$41.1K 0.03% 490
2026
Q1
$807K Buy
9,307
+4,558
+96% +$437K 0.04% 450
2025
Q4
$456K Buy
4,749
+648
+16% +$62.9K 0.02% 584
2025
Q3
$391K Buy
+4,101
New +$377K 0.02% 637
2021
Q1
Sell
-1,736
Closed -$203K 451
2020
Q4
$203K Buy
+1,736
New +$191K 0.04% 388
2020
Q1
Sell
-1,993
Closed -$236K 326
2019
Q4
$236K Buy
+1,993
New +$219K 0.07% 277
2018
Q4
Sell
-2,682
Closed -$264K 344
2018
Q3
$264K Buy
2,682
+149
+6% +$13.8K 0.07% 307
2018
Q2
$217K Buy
+2,533
New +$212K 0.07% 350
2016
Q1
Sell
-838
Closed -$64K 703
2015
Q4
$64K Buy
+838
New +$63.1K 0.03% 394

Other funds holding MDT

Ausdal Financial Partners's MDT Position: Q2 2026 in Review

Ausdal Financial Partners increased its Medtronic (MDT) stake by 5.5% in Q2 2026, buying an estimated $41.1K and bringing the position to 9,817 shares worth $768K. The position accounts for 0.03% of the portfolio, ranked #490.

Ausdal Financial Partners first reported a position in MDT in Q4 2015 and has held it in 9 quarters since. The position peaked at $807K in Q1 2026. 2,141 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ausdal Financial Partners held 9,817 shares of Medtronic worth $768K as of Q2 2026.
  • Ausdal Financial Partners bought 510 Medtronic shares in Q2 2026, an estimated $41.1K.
  • Medtronic made up 0.03% of Ausdal Financial Partners's portfolio in Q2 2026, its #490 holding.
  • Ausdal Financial Partners first reported a position in Medtronic in Q4 2015 and has held it in 9 quarters since.
  • Ausdal Financial Partners's Medtronic position peaked at $807K in Q1 2026.
  • 2,141 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ausdal Financial Partners's 13F filing for Q2 2026, filed 14 Aug 2026.